NVIDIA today launched more than two dozen new microservices that allow healthcare enterprises worldwide to take advantage of the latest advances in generative AI from anywhere and on any cloud.
The new suite of NVIDIA healthcare microservices includes optimized NVIDIA NIM™ AI models and workflows with industry-standard APIs, or application programming interfaces, to serve as building blocks for creating and deploying cloud-native applications. They offer advanced imaging, natural language and speech recognition, and digital biology generation, prediction and simulation.
Additionally, NVIDIA accelerated software development kits and tools, including Parabricks®, MONAI, NeMo™, Riva and Metropolis, can now be accessed as NVIDIA CUDA-X™ microservices to accelerate healthcare workflows for drug discovery, medical imaging and genomics analysis.
The microservices, 25 of which launched today, can accelerate transformation for healthcare companies as generative AI introduces numerous opportunities for pharmaceutical companies, doctors and hospitals. These include screening for trillions of drug compounds to advance medicine, gathering better patient data to aid early disease detection and implementing smarter digital assistants.
Researchers, developers and practitioners can use the microservices to easily integrate AI into new and existing applications and run them anywhere — from the cloud to on premises — equipping them with copilot capabilities to enhance their life-saving work.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.